clinical trials

See the following -

Clinovo - Webinar Series - Open Source Technologies For Clinical Trials

Staff Writer | YouTube | November 2, 2012

Marc Desgrousilliers, CTO of Clinovo, talks about open source technologies for clinical trials. Live demo of ClinCapture, Clinovo's open source electronic data capture (EDC) system. The development of open source technology in the clinical arena has been rapidly growing, explained top-tier panelists from leading pharmaceutical, biotechnology, and medical device companies at a Silicon Valley BioTalks. They described how open source technologies save time, improve re-usability and simplify the customization of systems to a company's needs.

Read More »

2050 Deadline For Tuberculosis

Kaniza Garari | Deccan Chronicle | August 26, 2013

It has been a challenge for the government of India to come up with a new drug to cure tuberculosis and scientists at IICT are keeping their fingers crossed as the new combination of PA824 moxifloxacin and pyrazinamide under the Open Source Drug Discovery has successfully entered phase-II of clinical trial. Read More »

4 Ways Blockchain Is the New Business Collaboration Tool

Lucas Mearian | Computer World | May 23, 2017

While blockchain may have cut its teeth on the cryptocurrency Bitcoin, the distributed electronic ledger technology is quickly making inroads across a variety of industries. That's mainly because of its innate security and its potential for improving systems  operations all while reducing costs and creating new revenue streams. This year, blockchain technology is expected to become a key business focus for many industries, according to a Deloitte survey conducted late last year...

Read More »

A Case for Open Peer Review for Clinical Trials

A few weeks ago I played the part of an expert witness in the Medical Journalist Association’s mock trial, Trials on Trial. The charge was: “Is the current system of publishing clinical trials fit for purpose?” The jury’s verdict was a resounding ‘no’. You can read more about the event in Jane Feinmann’s write up on the BMJ Group Blogs.

Read More »

A Look At Integration Between Mi-Forms And OpenClinica

Staff Writer | Mi-Co | July 3, 2013

For those of you who work in the clinical research industry, you have probably already heard of OpenClinica, the world’s leading open source software for data capture and management in clinical trials. Read More »

A Primer on the Open Source Movement from a Health Care Perspective

Open source, in myriad forms, has emerged as a significant development model that drives both innovation and technological dispersion. Ignore it at your peril, as did the major computer companies destroyed or totally remade by Linux and free software, or encyclopedia publishers by Wikipedia, or journalists and marketers by social media. The term "open source" was associated first with free software, but it goes far beyond software now. People around the world use open hardware, demand open government, share open data, and--yes--pursue open health. The field of health, in particular, will be transformed by open source principles in software, in research, in consultations and telemedicine, and in the various forms of data sharing all these processes call for.

Read More »

A Way For Biopharma To Disclose More Trial Data

Ken Getz | Medical Marketing & Media | December 26, 2012

[...] At a time when some regulatory bodies and biopharma companies are increasing their transparency initiatives involving access to clinical-trial data, disclosing trial results to volunteers could also go a long way toward strengthening public confidence. Read More »

Are digital health technologies really good for our health?

Christina Hernandez Sherwood | Fortune | August 31, 2015

Countless entrepreneurs around the world have launched digital health companies in the last decade and more than 100,000 mobile apps are currently on the market—all with the goal of making us healthier. But how many of these companies have concrete evidence to support their health claims? Not many, says Sean Duffy, co-founder and CEO of Omada Health, a digital health company that develops programs for people at risk for chronic disease. “It’s still rare,” he adds.

Read More »

Bad Pharma: Account Of The Bottomless Corruption Of The Pharma Industry Is A Stirring Call To Arms

Cory Doctorow | Boing Boing | November 6, 2012

I mentioned in September that Ben "Bad Science" Goldacre had a new book out, Bad Pharma: How drug companies mislead doctors and harm patients. I was sure at the time that this would be the usual excellent Goldacre fare -- lucid, thorough, and important. Now that I'm back from my own book tour, I've had a chance to read it and I'm pleased (or rather, furious -- more on this later) to report that this really is the usual, excellent Goldacre stuff. Read More »

Benefits, Challenges and Best Practices of Clinical Trials: Paper vs. Electronic Data Capture

On February 25th 2015, Clinovo hosted the 10th Session of the Silicon Valley BioTalks at HP’s headquarters in Palo Alto. The attendees consisted of life science industry professionals with the sole intent of discussing the benefits, challenges and best practices of paper-based clinical studies vs EDC based studies. To add a valuable experience to the conversation, the event featured a panel of 4 clinical trials professionals... Read More »

Bio-IT World Announces the Winners of Its Tenth Annual Best Practices Awards

Press Release | Bio-IT World, Cambridge Healthtech Institute (CHI) | April 30, 2014

Bio-IT World announced the winners of its tenth annual Best Practices Awards competition this morning in a plenary session at the 2014 Bio-IT World Conference & Expo in Boston. Grand prize winners were named in five life sciences categories highlighting best practices in clinical trial IT, research infrastructure, bioinformatics, cloud computing and data management from AstraZeneca and Tessella, U-BIOPRED, the Pistoia Alliance, Baylor College of Medicine, and Genentech. Read More »

Blockchain's Potential Use Cases for Healthcare: Hype or Reality?

Mike Miliard | Healthcare IT News | February 22, 2017

At HIMSS17 on Wednesday, IEEE Computer Society and the Personal Connected Health Alliance hosted a day-long event focused on the potentially transformative promise of an intriguing innovation: Blockchain. Kicking off the symposium, "Blockchain in Healthcare: A Rock Stars of Technology Event," Tamara StClaire, previous chief innovation officer at Conduent Health (formerly known as Xerox Healthcare), made the case that the bitcoin-derived secure digital ledger technology could just maybe offer the answer to an array of vexing healthcare challenges – not least of which is interoperability...

Read More »

Bloomberg Health Care Summit on "Connecting Healthcare Policy with Next Century Innovation"

Earlier this week, the Bloomberg Government Health Care Summit appropriately named "Mind the Gap: Connecting Healthcare Policy with Next Century Innovation", was held in Washington, D.C. It was convened to discuss perspectives of healthcare innovators, medical professionals, and government officials who are helping to redesign U.S. healthcare during a time of innovation. About 150 healthcare industry representatives were in attendance. One of our Open Health News (OHN) correspondents was there. Read More »

Breaking the Seal on Drug Research

Katie Thomas | New York Times | June 29, 2013

Together with a band of far-flung researchers and activists, [Dr. Peter Doshi] is trying to unearth data from clinical trials — complex studies that last for years and often involve thousands of patients across many countries — and make it public. Read More »

Cancer And Clinical Trials: The Role Of Big Data In Personalizing The Health Experience

Despite considerable progress in prevention and treatment, cancer remains the second leading cause of death in the United States. Even with the $50 billion pharmaceutical companies spend on research and development every year, any given cancer drug is ineffective in 75% of the patients receiving it. [...] Read More »